FBLG
FibroBiologics·NASDAQ
--
--(--)
--
--(--)
6.38 / 10
Outperform
Fund-flow analysis scores 7.42/10, indicating healthy liquidity. Small-cap inflows are positive (0.514), while block and larger orders lean negative; this divergence suggests institutional hesitation. Coupled with two analysts issuing Strong Buy ratings, the sentiment is mixed but slightly bullish—yet not enough to override weak fundamentals and poor technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-06
InstitutionD. Boral Capital
Times predicted14
Historical Win Rate42.9%
Is money flowing into or out of FBLG?
- FBLG holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.38/10 (Outperform).
